Go Pro

OraSure Technologies (OSUR) Stock Price, News & Analysis

OraSure Technologies logo
$3.37 +0.12 (+3.69%)
Closing price 09/14/2026 04:00 PM Eastern
Extended Trading
$3.36 -0.01 (-0.18%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About OraSure Technologies Stock (NASDAQ:OSUR)

Advanced

Key Stats

Today's Range
$3.22
$3.38
50-Day Range
$3.23
$4.32
52-Week Range
$2.08
$4.58
Volume
765,944 shs
Average Volume
389,545 shs
Market Capitalization
$232.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00
Consensus Rating
Reduce

Company Overview

OraSure Technologies, Inc. is a diagnostics and specimen-collection company that develops, manufactures and distributes point-of-care and at-home testing products, collection devices and laboratory technologies. Its solutions are used in infectious-disease screening, molecular testing, genomics, microbiome research and other applications requiring the collection, stabilization and analysis of biological samples.

The company is best known for its OraQuick portfolio of rapid tests, including oral-fluid tests for HIV and hepatitis C. OraSure also provides oral-fluid and other specimen-collection systems, laboratory collection and stabilization products, and molecular research technologies marketed under brands including DNA Genotek and OMNIgene. These products support clinical laboratories, public-health programs, healthcare providers, researchers and consumers.

OraSure serves customers in the United States and international markets through direct sales and distribution relationships. The company traces its roots to Epitope, Inc., a developer of oral-fluid diagnostic technologies, and adopted the OraSure Technologies name in 2000. Its shares trade on the Nasdaq Stock Market under the symbol OSUR.

AI Generated. May Contain Errors.

OraSure Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

OSUR MarketRank™: 

OraSure Technologies scored higher than 20% of companies evaluated by MarketBeat, and ranked 831st out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OraSure Technologies has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

  • Downside Risk

    OraSure Technologies has a consensus price target of $3.00, representing about 11.0% downside from its current price of $3.37.

  • Amount of Analyst Coverage

    OraSure Technologies has only been the subject of 1 research reports in the past 90 days.

  • Read more about OraSure Technologies' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OraSure Technologies is -4.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OraSure Technologies is -4.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    OraSure Technologies has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about OraSure Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    4.76% of the float of OraSure Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    OraSure Technologies has a short interest ratio ("days to cover") of 8.22.
  • Change versus previous month

    Short interest in OraSure Technologies has recently decreased by 0.43%, indicating that investor sentiment is improving.
  • Dividend Yield

    OraSure Technologies does not currently pay a dividend.

  • Dividend Growth

    OraSure Technologies does not have a long track record of dividend growth.

  • News Sentiment

    OraSure Technologies has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for OraSure Technologies this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added OraSure Technologies to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OraSure Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    4.70% of the stock of OraSure Technologies is held by insiders.

  • Percentage Held by Institutions

    93.50% of the stock of OraSure Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OraSure Technologies' insider trading history.
Receive OSUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OSUR Stock News Headlines

OraSure (OSUR) Returns To Profit, But Growth Remains Elusive
OraSure Technologies: Lack Of Near Term Catalysts
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
OraSure (OSUR) Q2 2026 Earnings Call Transcript
OraSure: Q2 Earnings Snapshot
OraSure Announces Second Quarter 2026 Financial Results
See More Headlines

OSUR Stock Analysis - Frequently Asked Questions

OraSure Technologies' stock was trading at $2.42 at the start of the year. Since then, OSUR stock has increased by 39.3% and is now trading at $3.37.

OraSure Technologies, Inc. (NASDAQ:OSUR) released its quarterly earnings results on Wednesday, February, 25th. The medical instruments supplier reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.02. The medical instruments supplier had revenue of $26.76 million for the quarter, compared to analyst estimates of $26.44 million. OraSure Technologies had a negative trailing twelve-month return on equity of 19.09% and a negative net margin of 43.70%.
Read the conference call transcript
.

OraSure Technologies' board authorized a stock buyback program on Monday, March 24th 2025, which permits the company to buy back $40,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 15.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

Top institutional investors of OraSure Technologies include BlackRock Inc. (9.09%), Private Management Group Inc. (5.51%), Altai Capital Management L.P. (5.24%) and Cannell Capital LLC (2.07%). Insiders that own company stock include Manner Carrie Eglinton, Kenneth J Mcgrath, Kathleen Gallagher Weber, Steven Kyle Boyd and John P Kenny.
View institutional ownership trends
.

Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OraSure Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW) and Adobe (ADBE).

Company Calendar

Last Earnings
2/25/2026
Today
9/14/2026
Next Earnings (Estimated)
11/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:OSUR
CIK
1116463
Employees
840
Year Founded
N/A

Price Target and Rating

High Price Target
$3.00
Low Price Target
$3.00
Potential Upside/Downside
-11.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.73 million
Net Margins
-43.70%
Pretax Margin
-41.48%
Return on Equity
-19.09%
Return on Assets
-16.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.88
Quick Ratio
7.68

Sales & Book Value

Annual Sales
$112.41 million
Price / Sales
2.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.75 per share
Price / Book
0.71

Miscellaneous

Outstanding Shares
68,969,000
Free Float
65,727,000
Market Cap
$232.43 million
Optionable
Optionable
Beta
0.99
10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:OSUR) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners